XML 49 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Revenue - Summary of Revenues Disaggregated by Product Classification and Reportable Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Disaggregation Of Revenue [Line Items]    
Total revenue $ 22,297 $ 22,616
Product Sales [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 10,102 9,974
Royalties [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 9,334 10,148
Research, Development and Other [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 2,861 2,494
Operating Segments [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 22,297 22,616
Operating Segments [Member] | Medical Device [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 16,196 17,404
Operating Segments [Member] | Medical Device [Member] | Product Sales [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 4,561 5,023
Operating Segments [Member] | Medical Device [Member] | Royalties [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 7,909 8,898
Operating Segments [Member] | Medical Device [Member] | Research, Development and Other [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 2,301 2,234
Operating Segments [Member] | Medical Device [Member] | License Fees [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 1,425 1,249
Operating Segments [Member] | In Vitro Diagnostics [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 6,101 5,212
Operating Segments [Member] | In Vitro Diagnostics [Member] | Product Sales [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue 5,541 4,952
Operating Segments [Member] | In Vitro Diagnostics [Member] | Research, Development and Other [Member]    
Disaggregation Of Revenue [Line Items]    
Total revenue $ 560 $ 260